Pharmacokinetics of EDP-323, a Potent, Once-Daily, Oral Antiviral Treatment for Respiratory Syncytial Virus

EDP-323, a Small Molecule L-Protein Inhibitor, in Development Against Respiratory Syncytial Virus

EDP-323, a Novel L-Protein Inhibitor, for the Treatment of Respiratory Syncytial Virus

In Vivo Efficacy of EDP-323, a Novel L-Protein Inhibitor, for the Treatment of Respiratory Syncytial Virus